EntryPoint Capital’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
DC
EntryPoint Capital's FLGT Position: Q2 2026 in Review
EntryPoint Capital increased its Fulgent Genetics (FLGT) stake by 78% in Q2 2026, buying an estimated $208K and bringing the position to 27,999 shares worth $575K. The position accounts for 0.14% of the portfolio, ranked #270.
EntryPoint Capital first reported a position in FLGT in Q4 2023 and has held it in 9 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.
- EntryPoint Capital held 27,999 shares of Fulgent Genetics worth $575K as of Q2 2026.
- EntryPoint Capital bought 12,254 Fulgent Genetics shares in Q2 2026, an estimated $208K.
- Fulgent Genetics made up 0.14% of EntryPoint Capital's portfolio in Q2 2026, its #270 holding.
- EntryPoint Capital first reported a position in Fulgent Genetics in Q4 2023 and has held it in 9 quarters since.
- 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.
Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.